Skip to content

AS PHARMA CONSULTING

Active
Private limited company·Detailhandel in farmaceutische producten· 3 yrs active
Avenue de la Gare(FL) 14 ·6220 Fleurus, Belgium
KBO/BCE: BE 0802.302.143
Watch Print / PDF
Age3 yrs
Real estate1 parcel · 425 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of AS PHARMA CONSULTING is 2.3% (moderate). The 2024 annual accounts show equity of €101k and a net result of €97k. Its solvency ranks better than 88% of 6695 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Signals

1 signal · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 88% of 6695 peers (2024). A comfortable equity buffer.
View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.3% Moderate
0%0,5%1,5%4%10%≥25%
Young company +Higher-failure-rate sector +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€97k
Working capital€79k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 28-08-2025 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 70.7% 20.4%
better than 88% of 6695 sector peers
Net result €97k €4k
better than 95% of 6675 sector peers
Equity €101k €16k
better than 86% of 6709 sector peers
Gross operating margin €138k €24k
better than 88% of 6654 sector peers
Total assets €143k €94k
better than 62% of 6699 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Fiscal year2024
Revenue-
EBITDA€134k
Net profit€97k
Cash flow€101k
Staff costs-
Income taxes€28k
Dividends-
Total assets€143k
Equity€101k
Debt€42k
of which ≤ 1y€42k
of which > 1y-
Working capital€79k
Employees (FTE)-
Ratios (computed)
2024
Current ratio2.88
Quick ratio2.88
Working capital ratio55.1%
Solvency70.7%
Debt / equity0.42
Long-term debt ratio-
Interest coverage23.15
Gross margin-
Net margin-
ROA68.2%
ROE96.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€143k
Fixed assets 21/28€22k
Intangible fixed assets 21€17k
Tangible fixed assets 22/27€5k
Current assets 29/58€120k
Amounts receivable within one year 40/41€16k
Cash & bank 54/58€103k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€143k
Equity 10/15€101k
Contributions / capital 10/11€4k
Reserves 13€97k
Accumulated profits (losses) 14€40
Amounts payable 17/49€42k
Amounts payable within one year 42/48€42k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€138k
Operating result 9901€130k
Financial income 75€382
Financial charges 65€6k
Result before taxes 9903€125k
Income taxes 67/77€28k
Net result for the period 9904€97k
Result to be appropriated 9905€97k
Ratios computed by Checked.

Health barometer

FY 2024 · computed
93 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
AS PHARMA CONSULTING
Avenue de la Gare(FL) 14, 6220 FleurusDetailhandel in farmaceutische producten
since 20232.345.774.259
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area425 m²
Buildings1
Building footprint183 m²
Volume (LiDAR)2,561 m³
Tallest building15.7 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52021C0178/00T000 Wallonia 425 m² 1 · 183 m² 15.7 m · 5 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health93Profitability100Solvency100Growth50Stability79
84 / 100

Exceptional profile, strong across almost every axis.

Health 93
Profitability 100
Solvency 100
Growth 50
Stability 79

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Apotheken47730Detailhandel in farmaceutische producten47730Detailhandel in cosmetica en toiletartikelen in gespecialiseerde winkels47750Detailhandel in cosmetica en toiletartikelen47750Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990
Primary activity highlighted.
Names & trade names
Legal nameFR AS PHARMA CONSULTING
Registered office
Avenue de la Gare(FL) 14 bus 5
6220 Fleurus, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.